AWGLSCP
RPID icon

ABG-WTT Global Life Science Capital Partners’s Rapid Micro Biosystems RPID Stock Holding History

ABG-WTT Global Life Science Capital Partners’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.2M Hold
1,848,296
– – 37.39% 2
2026
Q1 		$4.2M Hold
1,848,296
– – 34.13% 2
2025
Q4 		$5.36M Hold
1,848,296
– – 35.62% 2
2025
Q3 		$6.17M Hold
1,848,296
– – 33.06% 2
2025
Q2 		$6.38M Hold
1,848,296
– – 23.83% 2
2025
Q1 		$4.88M Buy
1,848,296
+810,000
+78% +$1.85M 12.73% 3
2024
Q4 		$934K Hold
1,038,296
– – 2.14% 3
2024
Q3 		$924K Hold
1,038,296
– – 4.59% 2
2024
Q2 		$685K Hold
1,038,296
– – 2.29% 2
2024
Q1 		$768K Hold
1,038,296
– – 1.85% 2
2023
Q4 		$768K Hold
1,038,296
– – 1.5% 3
2023
Q3 		$1.12M Hold
1,038,296
– – 5.38% 3
2023
Q2 		$1.04M Hold
1,038,296
– – 18.84% 2
2023
Q1 		$1.36M Hold
1,038,296
– – 21.45% 2
2022
Q4 		$1.17M Hold
1,038,296
– – 18.96% 2
2022
Q3 		$3.35M Hold
1,038,296
– – 20.94% 2
2022
Q2 		$4.46M Hold
1,038,296
– – 15.75% 2
2022
Q1 		$7.05M Buy
+1,038,296
New +$7.65M 57.23% 1

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EFA
Evernest Financial Advisors Carmel, Indiana $478M AUM 24% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ABG-WTT Global Life Science Capital Partners's RPID Position: Q2 2026 in Review

ABG-WTT Global Life Science Capital Partners held its Rapid Micro Biosystems (RPID) position steady in Q2 2026 at 1,848,296 shares worth $3.2M. The position accounts for 37.39% of the portfolio, ranked #2.

ABG-WTT Global Life Science Capital Partners first reported a position in RPID in Q1 2022 and has held it in 18 quarters since. The position peaked at $7.05M in Q1 2022. 34 funds tracked by Wall St. Rank hold RPID as of Q2 2026.

  • ABG-WTT Global Life Science Capital Partners held 1,848,296 shares of Rapid Micro Biosystems worth $3.2M as of Q2 2026.
  • ABG-WTT Global Life Science Capital Partners left its Rapid Micro Biosystems share count unchanged in Q2 2026.
  • Rapid Micro Biosystems made up 37.39% of ABG-WTT Global Life Science Capital Partners's portfolio in Q2 2026, its #2 holding.
  • ABG-WTT Global Life Science Capital Partners first reported a position in Rapid Micro Biosystems in Q1 2022 and has held it in 18 quarters since.
  • ABG-WTT Global Life Science Capital Partners's Rapid Micro Biosystems position peaked at $7.05M in Q1 2022.
  • 34 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q2 2026.

Based on ABG-WTT Global Life Science Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.